Vycor Medical, Inc.

Equities

VYCO

US92921M2035

Medical Equipment, Supplies & Distribution

Delayed OTC Markets Other stock markets 15:44:41 23/05/2024 BST			5-day change	1st Jan Change
0.0775 ^USD	-9.62%		-9.67%	+0.39%

04-16	Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Vycor Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Vycor Medical, Inc Appoints Peter C. Zachariou as Chief Executive Officer

January 07, 2014 at 09:24 pm

Vycor Medical Inc. appointed Peter C. Zachariou, Executive Vice President, to the additional role as the company's Chief Executive Officer. Peter C. Zachariou was appointed a Director of the company in May 2010, Executive Vice President in September 2010 and Chief Executive Officer in December 2013.

Latest news about Vycor Medical, Inc.

Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-16	CI
Vycor Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Vycor Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23	CI
Vycor Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/04/23	CI
Vycor Medical, Inc. Auditor Raises 'Going Concern' Doubt	13/04/23	CI
Vycor Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
Vycor Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/08/22	CI
Vycor Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	10/05/22	CI
Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	13/04/22	CI
Vycor Medical, Inc. Auditor Raises 'Going Concern' Doubt	12/04/22	CI
Vycor Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/11/21	CI
Vycor Medical, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021	16/08/21	CI
Vycor Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	14/05/21	CI
Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	31/03/21	CI
Vycor Medical, Inc. Announces Board Resignations	22/03/21	CI
Vycor Medical, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	13/11/20	CI
Vycor Medical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	17/08/20	CI
Vycor Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	12/05/20	CI
Vycor Medical, Inc. Announces Resignation of Oscar Bronsther as Director, Effective July 1, 2020	27/03/20	CI
Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	27/03/20	CI
Vycor Medical, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	12/11/19	CI
Vycor Medical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	09/08/19	CI
Vycor Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	13/05/19	CI
Vycor Medical Inc. Reports Consolidated Earnings Results for the Year Ended December 31, 2018	29/03/19	CI

Chart Vycor Medical, Inc.

Duration

Period

More charts

Company Profile

Vycor Medical, Inc. provides surgical and therapeutic solutions. The Company designs, develops and markets neurological medical devices and therapies. The Company operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment designs, develops and markets medical devices for use in neurosurgery. The NovaVision segment provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. Vycor Medical's product Vycor Medical's ViewSite Brain Access System (VBAS) is a next generation retraction and access system. Vycor Medical focuses on brain and cervical surgical access systems for sale to hospitals and medical professionals. NovaVision's products include Vision Restoration Therapy (VRT), NeuroEyeCoach and Neuro-Eye Therapy (NeEt). The Company operates in the United States and Europe.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
VYCOR MEDICAL, INC.	+0.39%	2.8M
ABBOTT LABORATORIES	-5.07%	182B
MEDTRONIC PLC	+0.10%	114B
BECTON, DICKINSON AND COMPANY	-5.39%	67.76B
DEXCOM, INC.	+3.11%	51.91B
CENCORA, INC.	+7.04%	43.23B
HOYA CORPORATION	+6.07%	41.07B
METTLER-TOLEDO INTERNATIONAL, INC.	+23.19%	32.07B
TERUMO CORPORATION	+15.86%	25B
ZIMMER BIOMET HOLDINGS, INC.	-3.08%	24.55B

Other Medical Equipment, Supplies & Distribution